People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nerveda Llc | — | Biotechnology | Series A | $18.0M | $141.0M | 2011 |
David Maurer-Hollaender at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Maurer-Hollaender on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cam Gallagher | 1 | 7 |
| James Weil | 1 | 3 |
| Adam Cohen | 1 | 3 |
| Stewart Reid | 1 | 1 |
| Thomas Lionelli | 1 | 1 |
| Odo Habeck | 1 | 1 |
| Rob Ades | 1 | 1 |
| Debra Widmann | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.